Funding for this research was provided by:
Instituto de Salud Carlos III (PI16/00904)
Teva Pharmaceutical Industries (Not applicable)
F. Hoffmann-La Roche (Not applicable)
Pas a Pas (Not applicable)
Save the mama (Not applicable)
Text and Data Mining valid from 2019-01-09
Received: 20 August 2018
Accepted: 10 December 2018
First Online: 9 January 2019
Ethics approval and consent to participate
: This study was approved by the Institutional Review Board of Hospital Vall d’Hebron (Barcelona) AC/R(AG)143/2012(3455). All patients provided written informed consent.
: Not applicable.
: Advisory role of AP for Nanostring Technologies. Advisory Role of JG for Roche. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.